Literature DB >> 16733808

Increased insulin secretion by muscarinic M1 and M3 receptor function from rat pancreatic islets in vitro.

T R Renuka1, Remya Robinson, C S Paulose.   

Abstract

Parasympathetic system plays an important role in insulin secretion from the pancreas. Cholinergic effect on pancreatic beta cells exerts primarily through muscarinic receptors. In the present study we investigated the specific role of muscarinic M1 and M3 receptors in glucose induced insulin secretion from rat pancreatic islets in vitro. The involvement of muscarinic receptors was studied using the antagonist atropine. The role of muscarinic M1 and M3 receptor subtypes was studied using subtype specific antagonists. Acetylcholine agonist, carbachol, stimulated glucose induced insulin secretion at low concentrations (10(-8)-10(-5) M) with a maximum stimulation at 10(-7) M concentration. Carbachol-stimulated insulin secretion was inhibited by atropine confirming the role of muscarinic receptors in cholinergic induced insulin secretion. Both M1 and M3 receptor antagonists blocked insulin secretion induced by carbachol. The results show that M3 receptors are functionally more prominent at 20 mM glucose concentration when compared to M1 receptors. Our studies suggest that muscarinic M1 and M3 receptors function differentially regulate glucose induced insulin secretion, which has clinical significance in glucose homeostasis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16733808     DOI: 10.1007/s11064-005-9022-6

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  26 in total

1.  Novel effects of insulin secretagogues on capacitation of insulin release and survival of cultured pancreatic islets.

Authors:  M J MacDonald; L A Fahien; D I McKenzie; S M Moran
Journal:  Am J Physiol       Date:  1990-10

2.  Muscarinic receptors in pancreatic islets of the rat. Demonstration and dependence on long-term glucose environment.

Authors:  V Grill; C G Ostenson
Journal:  Biochim Biophys Acta       Date:  1983-03-31

3.  Effects of stimulation of the vagus nerve on insulin secretion.

Authors:  A Kaneto; K Kosaka; K Nakao
Journal:  Endocrinology       Date:  1967-03       Impact factor: 4.736

4.  Insulin secretion from ob/ob mouse pancreatic islets: effects of neurotransmitters.

Authors:  T M Tassava; T Okuda; D R Romsos
Journal:  Am J Physiol       Date:  1992-03

5.  The muscarinic receptor subtype in mouse pancreatic B-cells.

Authors:  J C Henquin; M Nenquin
Journal:  FEBS Lett       Date:  1988-08-15       Impact factor: 4.124

6.  Induction of DNA synthesis in primary cultures of rat hepatocytes by serotonin: possible involvement of serotonin S2 receptor.

Authors:  S Balasubramanian; C S Paulose
Journal:  Hepatology       Date:  1998-01       Impact factor: 17.425

7.  Decreased 5-HT1A receptor gene expression and 5-HT1A receptor protein in the cerebral cortex and brain stem during pancreatic regeneration in rats.

Authors:  Valiya veettil Mohanan; S Balarama Kaimal; Cheramadathikudyil S Paulose
Journal:  Neurochem Res       Date:  2005-01       Impact factor: 3.996

8.  Alterations in the muscarinic M1 and M3 receptor gene expression in the brain stem during pancreatic regeneration and insulin secretion in weanling rats.

Authors:  T R Renuka; Das V Ani; C S Paulose
Journal:  Life Sci       Date:  2004-09-24       Impact factor: 5.037

9.  Muscarinic stimulation of phosphatidylinositol metabolism in atria.

Authors:  S L Brown; J H Brown
Journal:  Mol Pharmacol       Date:  1983-11       Impact factor: 4.436

10.  Oxotremorine-m potentiation of glucose-induced insulin release from rat islets involves M3 muscarinic receptors.

Authors:  A C Boschero; M Szpak-Glasman; E M Carneiro; S Bordin; I Paul; E Rojas; I Atwater
Journal:  Am J Physiol       Date:  1995-02
View more
  10 in total

1.  Xenin-25 potentiates glucose-dependent insulinotropic polypeptide action via a novel cholinergic relay mechanism.

Authors:  Burton M Wice; Songyan Wang; Dan L Crimmins; Kelly A Diggs-Andrews; Matthew C Althage; Eric L Ford; Hung Tran; Matthew Ohlendorf; Terry A Griest; Qiuling Wang; Simon J Fisher; Jack H Ladenson; Kenneth S Polonsky
Journal:  J Biol Chem       Date:  2010-04-26       Impact factor: 5.157

2.  Long lasting synchronization of calcium oscillations by cholinergic stimulation in isolated pancreatic islets.

Authors:  Min Zhang; Bernard Fendler; Bradford Peercy; Pranay Goel; Richard Bertram; Arthur Sherman; Leslie Satin
Journal:  Biophys J       Date:  2008-08-15       Impact factor: 4.033

Review 3.  Classifying antipsychotic agents : need for new terminology.

Authors:  Ripu D Jindal; Matcheri S Keshavan
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

4.  Age-related changes in the insulin receptor β in the gerbil hippocampus.

Authors:  Chan Woo Park; Ki-Yeon Yoo; In Koo Hwang; Jung Hoon Choi; Choong Hyun Lee; Ok Kyu Park; Jun Hwi Cho; Yun Lyul Lee; Hyung-Cheul Shin; Moo-Ho Won
Journal:  Neurochem Res       Date:  2009-12       Impact factor: 3.996

Review 5.  New insights into the architecture of the islet of Langerhans: a focused cross-species assessment.

Authors:  Rafael Arrojo e Drigo; Yusuf Ali; Juan Diez; Dinesh Kumar Srinivasan; Per-Olof Berggren; Bernhard O Boehm
Journal:  Diabetologia       Date:  2015-07-28       Impact factor: 10.122

6.  Xenin-25 increases cytosolic free calcium levels and acetylcholine release from a subset of myenteric neurons.

Authors:  Sheng Zhang; Krzysztof Hyrc; Songyan Wang; Burton M Wice
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-10-18       Impact factor: 4.052

7.  Hormonal Responses to Cholinergic Input Are Different in Humans with and without Type 2 Diabetes Mellitus.

Authors:  Sara Chowdhury; Songyan Wang; Judit Dunai; Rachel Kilpatrick; Lauren Z Oestricker; Michael J Wallendorf; Bruce W Patterson; Dominic N Reeds; Burton M Wice
Journal:  PLoS One       Date:  2016-06-15       Impact factor: 3.240

8.  Cholinergic signaling mediates the effects of xenin-25 on secretion of pancreatic polypeptide but not insulin or glucagon in humans with impaired glucose tolerance.

Authors:  Songyan Wang; Lauren Z Oestricker; Michael J Wallendorf; Karin Sterl; Judit Dunai; C Rachel Kilpatrick; Bruce W Patterson; Dominic N Reeds; Burton M Wice
Journal:  PLoS One       Date:  2018-02-21       Impact factor: 3.240

9.  Neonatal treatment with scopolamine butylbromide prevents metabolic dysfunction in male rats.

Authors:  Ananda Malta; Aline Amenencia de Souza; Tatiane Aparecida Ribeiro; Flávio Andrade Francisco; Audrei Pavanello; Kelly Valério Prates; Laize Peron Tófolo; Rosiane Aparecida Miranda; Júlio Cezar de Oliveira; Isabela Peixoto Martins; Carina Previate; Rodrigo Mello Gomes; Claudinéia Conationi da Silva Franco; Maria Raquel Marçal Natali; Kesia Palma-Rigo; Paulo Cezar de Freitas Mathias
Journal:  Sci Rep       Date:  2016-08-26       Impact factor: 4.379

Review 10.  Antipsychotic Drugs: From Receptor-binding Profiles to Metabolic Side Effects.

Authors:  Spyridon Siafis; Dimitrios Tzachanis; Myrto Samara; Georgios Papazisis
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.